Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Yale University
New Haven, Connecticut
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 144
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Craig Crews | Conflict of Interest | Halda Therapeutics OpCo | $200,000 - $249,999 | 2019 |
| Laura Niklason | Conflict of Interest | Humacyte, Inc. | $150,000 - $199,999 | 2016 |
| Laura Niklason | Conflict of Interest | Humacyte, Inc. | $150,000 - $199,999 | 2017 |
| Laura E. Niklason | Conflict of Interest | Humacyte, Inc. | $150,000 - $199,999 | 2016 |
| Laura Niklason | Conflict of Interest | Humacyte, Inc. | $100,000 - $149,999 | 2017 |
| Craig Crews | Conflict of Interest | Arvinas, LLC | $80,000 - $99,999 | 2015 |
| Craig Crews | Conflict of Interest | Arvinas, Inc. (formerly Arvinas, LLC) | $80,000 - $99,999 | 2014 |
| Jean-Francois Geschwind | Conflict of Interest | BTG International, Inc. | $60,000 - $79,999 | 2015 |
| William Tamborlane | Conflict of Interest | Insuline Medical, Ltd. | $60,000 - $79,999 | 2014 |
| Yung-Chi Cheng | Conflict of Interest | Kadmon Corporation | $60,000 - $79,999 | 2013 |
| William Tamborlane | Conflict of Interest | Insuline Medical, Ltd. | $60,000 - $79,999 | 2014 |
| Ana C. Anderson | Conflict of Interest | Potenza Therapeutics | $40,000 - $59,999 | 2017 |
| Michael Girardi | Conflict of Interest | Nanosive | $40,000 - $59,999 | 2018 |
| William Tamborlane | Conflict of Interest | Insuline Medical, Ltd. | $40,000 - $59,999 | 2014 |
| W. Mark Saltzman | Conflict of Interest | Nanosive | $40,000 - $59,999 | 2018 |
| William Tamborlane | Conflict of Interest | Insuline Medical, Ltd. | $40,000 - $59,999 | 2014 |
| Craig Crews | Conflict of Interest | Canaan Partners | $40,000 - $59,999 | 2014 |
| William Tamborlane | Conflict of Interest | Novo Nordisk Pharmaceuticals | $20,000 - $39,999 | 2014 |
| Peter Glazer | Conflict of Interest | Patrys Limited | $20,000 - $39,999 | 2016 |
| Peter Glazer | Conflict of Interest | Patrys, Limited | $20,000 - $39,999 | 2017 |
| Kathleen Carroll | Conflict of Interest | CBT4CBT, LLC | $20,000 - $39,999 | 2018 |
| Kathleen Carroll | Conflict of Interest | CBT4CBT, LLC | $20,000 - $39,999 | 2018 |
| William Tamborlane | Conflict of Interest | Medtronic Diabetes | $20,000 - $39,999 | 2014 |
| Peter Glazer | Conflict of Interest | TruCode Gene Repair, Inc. | $20,000 - $39,999 | 2019 |
| Peter Glazer | Conflict of Interest | Tru Code (formerly PNA Innovations) | $20,000 - $39,999 | 2017 |
| W. Mark Saltzman | Conflict of Interest | Tru Code (formerly PNA Innovations) | $20,000 - $39,999 | 2017 |
| Lieping Chen | Conflict of Interest | Bristol-Myers Squibb, Inc. | $20,000 - $39,999 | 2015 |
| Peter Glazer | Conflict of Interest | TruCode | $20,000 - $39,999 | 2018 |
| W. Mark Saltzman | Conflict of Interest | TruCode | $20,000 - $39,999 | 2018 |
| Marie Egan | Conflict of Interest | Tru Code (formerly PNA Innovations, Inc.) | $20,000 - $39,999 | 2017 |
| Kathleen Carroll | Conflict of Interest | CBT4CBT, LLC | $20,000 - $39,999 | 2018 |
| Kathleen Carroll | Conflict of Interest | CBT4CBT, LLC. | $20,000 - $39,999 | 2018 |
| William Tamborlane | Conflict of Interest | Grove Instruments | $20,000 - $39,999 | 2014 |
| William Tamborlane | Conflict of Interest | Insuline Medical, Ltd. | $20,000 - $39,999 | 2013 |
| Daniel Geschwind | Conflict of Interest | SynapDX | $20,000 - $39,999 | 2013 |
| Jean-Francois Geschwind | Conflict of Interest | Laboratoire Guerbet | $20,000 - $39,999 | 2015 |
| Lieping Chen | Conflict of Interest | Bristol Meyers Squibb, Inc. | $20,000 - $39,999 | 2012 |
| Lieping Chen | Conflict of Interest | AstraZeneca Pharmaceuticals | $20,000 - $39,999 | 2015 |
| Stephen Strittmatter | Conflict of Interest | Axerion Therapeutics, Inc. | $20,000 - $39,999 | 2016 |
| Jean-Francois Geschwind | Conflict of Interest | Philips HealthCare | $20,000 - $39,999 | 2015 |
| W. Mark Saltzman | Conflict of Interest | TruCode Gene Repair, Inc. | $20,000 - $39,999 | 2019 |
| William Tamborlane | Conflict of Interest | Insuline Medical, Ltd. | $20,000 - $39,999 | 2013 |
| Peter Glazer | Conflict of Interest | Cybrexa Therapeutics | $20,000 - $39,999 | 2017 |
| William Tamborlane | Conflict of Interest | Bristol-Myers Squibb | $20,000 - $39,999 | 2014 |
| William Tamborlane | Conflict of Interest | Grove Instruments | $20,000 - $39,999 | 2014 |
| Sherry McKee | Conflict of Interest | Cerecor, Inc. | $20,000 - $39,999 | 2016 |
| Marie Egan | Conflict of Interest | TruCode | $20,000 - $39,999 | 2018 |
| William Tamborlane | Conflict of Interest | Novo Nordisk Pharmaceuticals | $20,000 - $39,999 | 2014 |
| Marie Egan | Conflict of Interest | PNA Innovations, Inc. | $20,000 - $39,999 | 2017 |
| Sarah Goldberg | Conflict of Interest | AstraZeneca | $10,000 - $19,999 | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.